Benefits for Physicians

RTsafe’s innovative technology brings you confidence and control across the entire treatment process. Confirmation of prescribed doses in a simulated environment verifies the efficacy of your plans ahead of treatment execution. As a result, even your most demanding cases (such as multiple brain metastases) become easier to undertake.

Your ability to visualize a patient’s treatment through individualized simulation ensures the desired outcome while simultaneously minimizing the possibility of debilitating side effects. You have the option to share the simulation with the patient, and help them to understand the whole process. In this way, you can provide exceptional patient involvement and empowerment by offering compelling evidence of safe and accurate treatment ahead of a medical intervention.

Additionally, you can store data from the simulation in each patient’s medical record as
proof of good medical practice.

product_pseudopatient

PseudoPatient®

Patient Treatment Verification Redefined. Safety Personalized.

PseudoPatient® is an FDA cleared device constructed by the real patient’s CT data using highly accurate 3D printing technology. It forms an anatomically accurate replica of patient’s head, providing physicians and medical physicists with either direct dose measurements of anatomic regions of high interest (point, 2D), or a full relative 3D dose map, ideal for demanding SRS cases, such as small benign tumors.

Publications

  • Validation of PTV margin for Gamma Knife Icon frameless treatment using a PseudoPatient® Prime anthropomorphic phantom

    Eun Young Han, Parmeswaran Diagaradjane, Dershan Luo, Yao Ding, Georgios Kalaitzakis, Emmanouil Zoros, Kyveli Zourari, Themistoklis Boursianis, Evangelos Pappas, Zhifei Wen, Jihong Wang, Tina Marie Briere Journal of applied Clinical Medical Physics, (2020)
  • Dosimetric performance of the Elekta Unity MR-linac system: 2D and 3D dosimetry in anthropomorphic inhomogeneous geometry

    E Pappas, G Kalaitzakis , T Boursianis , E Zoros , KZourari , E P Pappas , D Makris , I Seimenis , E Efstathopoulos and T G Maris Phys.Med.Biol.,November 2019

Request a quote

See Whats new at RTsafe

RTsafe & Mercurius Health launch a collaboration to promote safe and auditable SRS and SBRT/SABR treatments.

RTsafe & Mercurius Health launch a collaboration to promote safe and auditable SRS and SBRT/SABR treatments.

Announcements
Athens, Greece   –   November 9, 2020 RTsafe and Mercurius Health today proudly announced that they have launched a collaboration based...
Read More
Webinar – Prime Phantom – Periodic End-To-End QA in SRS

Webinar – Prime Phantom – Periodic End-To-End QA in SRS

Webinars
Join our webinar on October 16, at 16:00 EEST lead by Prof. Niko Papanikolaou, titled “Prime Phantom – Periodic End-To-End...
Read More
RTsafe to exhibit at ASTRO 2020

RTsafe to exhibit at ASTRO 2020

Conferences - Tradeshows
ASTRO 2020 will be held between October 23-28, 2020 this time virtually! We are delighted to be a part of...
Read More